Impact of continued administration of tolvaptan on cirrhotic patients with ascites

Abstract Background The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites. We investigated the outcome of long-term treatment. Methods This was a single-center retrospective study. Overall, 170 cirrhotic patients (95 males, median age 63 years) were enroll...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomomi Kogiso (Autor), Takaomi Sagawa (Autor), Kazuhisa Kodama (Autor), Makiko Taniai (Autor), Katsutoshi Tokushige (Autor)
Formato: Libro
Publicado: BMC, 2018-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible